{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:22:30Z","timestamp":1791030150278,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1124\/dmd.112.045682","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T15:41:57Z","timestamp":1340811717000},"page":"1909-1916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Microdialysis Evaluation of Clozapine and N-Desmethylclozapine Pharmacokinetics in Rat Brain"],"prefix":"10.1016","volume":"40","author":[{"given":"Thomas IFH.","family":"Cremers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Flik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corry","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert E.","family":"Stratford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.045682_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/bdd.562","article-title":"Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats","volume":"28","author":"Bundgaard","year":"2007","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.045682_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vascn.2006.07.001","article-title":"An integrated microdialysis rat model for multiple pharmacokinetic\/pharmacodynamic investigations of serotonergic agents","volume":"55","author":"Bundgaard","year":"2007","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/dmd.112.045682_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/dmd.111.043083","article-title":"Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice","volume":"40","author":"Bundgaard","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045682_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/pgs.09.51","article-title":"ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients","volume":"10","author":"Consoli","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.112.045682_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","article-title":"Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993\u20132007","volume":"32","author":"Couchman","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.112.045682_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneumeth.2008.12.010","article-title":"Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique","volume":"178","author":"Cremers","year":"2009","journal-title":"J Neurosci Methods"},{"key":"10.1124\/dmd.112.045682_bib7","doi-asserted-by":"crossref","first-page":"E532","DOI":"10.1208\/aapsj070354","article-title":"Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling","volume":"7","author":"de Lange","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/dmd.112.045682_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","article-title":"The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A\/1B knockout mouse model","volume":"33","author":"Doran","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045682_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1211\/0022357043969","article-title":"Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds\u2013implications for pharmacokinetics of selected substrates","volume":"56","author":"El Ela","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.112.045682_bib10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1124\/dmd.107.015222","article-title":"In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids","volume":"35","author":"Frid\u00e9n","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045682_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1124\/dmd.112.045682_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/JCP.0b013e3181acc372","article-title":"ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine","volume":"29","author":"Jaquenoud Sirot","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.112.045682_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.045682_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.107.119560","article-title":"Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data","volume":"323","author":"Kalvass","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045682_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4088\/JCP.10r06264yel","article-title":"Past and present progress in the pharmacologic treatment of schizophrenia","volume":"71","author":"Kane","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/dmd.112.045682_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.108.023119","article-title":"Microdialysis evaluation of atomoxetine brain penetration and central nervous system pharmacokinetics in rats","volume":"37","author":"Kielbasa","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045682_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1124\/dmd.111.043554","article-title":"Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses","volume":"40","author":"Kielbasa","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045682_bib18","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/jpet.104.079319","article-title":"Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding","volume":"313","author":"Liu","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045682_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/dmd.108.024125","article-title":"Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid","volume":"37","author":"Liu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045682_bib20","first-page":"30","article-title":"Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations","volume":"27","author":"Llorca","year":"2002","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/dmd.112.045682_bib21","series-title":"Global Burden of Disease and Risk Factors","article-title":"The burden of disease and mortality by condition: Data, methods, and results for 2001","author":"Mathers","year":"2006"},{"key":"10.1124\/dmd.112.045682_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/dmd.104.001222","article-title":"Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice","volume":"33","author":"Maurer","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045682_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.112.045682_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejphar.2008.02.005","article-title":"Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics","volume":"584","author":"Olsen","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.112.045682_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002130050028","article-title":"Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics","volume":"148","author":"Spina","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.112.045682_bib26","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/jpet.105.092916","article-title":"Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain","volume":"316","author":"Summerfield","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045682_bib27","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1023\/B:PHAM.0000041468.00587.c6","article-title":"An integrated model for the analysis of pharmacokinetic data from microdialysis experiments","volume":"21","author":"Tunblad","year":"2004","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.045682_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.112.045682_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145704004390","article-title":"The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein","volume":"7","author":"Wang","year":"2004","journal-title":"Intl J Neuropsychopharmacol"},{"key":"10.1124\/dmd.112.045682_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-006-0437-9","article-title":"Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein","volume":"187","author":"Wang","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.112.045682_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1742-7843.2008.00298.x","article-title":"Antipsychotic drugs inhibit the function of breast cancer resistance protein","volume":"103","author":"Wang","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.112.045682_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/dmd.108.022814","article-title":"Receptor occupancy and brain free fraction","volume":"37","author":"Watson","year":"2009","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624061361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624061361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.045682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:45:51Z","timestamp":1739904351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624061361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0090955624061361"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.045682","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microdialysis Evaluation of Clozapine and N-Desmethylclozapine Pharmacokinetics in Rat Brain","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.045682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}